Tumor-resident TLR2 also essential for the tumor-triggered elevation of major histocompatibility complex class I, which not only increased antigen presentation but also contributed to the proliferation and activation of CD8+ T cells [36, 37]. The gene discussed is CD8A; the disease is neoplasm.